Provided by Tiger Trade Technology Pte. Ltd.

Insulet

142.88
-2.2500-1.55%
Volume:16.77K
Turnover:2.40M
Market Cap:9.90B
PE:26.97
High:143.59
Open:142.93
Low:142.01
Close:145.13
52wk High:354.88
52wk Low:126.40
Shares:69.26M
Float Shares:69.07M
Volume Ratio:0.90
T/O Rate:0.02%
Dividend:- -
Dividend Rate:- -
EPS(TTM):5.30
EPS(LYR):3.48
ROE:26.02%
ROA:9.71%
PB:6.96
PE(LYR):41.07

Loading ...

Insulet is Maintained at Outperform by Evercore ISI Group

Dow Jones
·
Jul 07

Evercore ISI Adjusts Price Target on Insulet to $180 From $200

MT Newswires Live
·
Jul 06

Insulet Corp. Stock Outperforms Competitors on Strong Trading Day

Dow Jones
·
Jul 03

Insulet Files Form 3 Disclosing Jonathan Jay Mazelsky as Director Beneficial Owner

Reuters
·
Jul 03

Insulet Recalls Omnipod Pods After Insulin-Delivery Failure Risk Identified, FDA Says

MT Newswires Live
·
Jul 03

FDA says Insulet recalled certain Omnipod Pods

TIPRANKS
·
Jul 03

US FDA Classifies Insulet Omnipod Pods Recall as Class I Due to Serious Injury Risk

Reuters
·
Jul 03

US FDA - Insulet Reports 24 Serious Injuries, no Deaths from Omnipod Pods Issue as of May 20

THOMSON REUTERS
·
Jul 03

Insulet’s EVOLVE Trial Targets Big Type 2 Diabetes Opportunity With Omnipod M

TIPRANKS
·
Jul 03

Omnipod 6 vs. Omnipod 5: A Fresh Clinical Look at Insulet’s Next Growth Catalyst

TIPRANKS
·
Jul 03

Insulet’s Optimal-B Study: Real-World Omnipod 5 Data Investors Should Watch

TIPRANKS
·
Jul 03

Dexcom Inc. Stock Outperforms Competitors on Strong Trading Day

Dow Jones
·
Jul 02

Insulet to Report Q2 2026 Results, Host Conference Call

Reuters
·
Jul 01

Press Release: Insulet to Announce Second Quarter 2026 Financial Results on August 5, 2026

Dow Jones
·
Jul 01

Insulet (PODD) After Russell Index Inclusion With Fair Value Still In Focus

Simply Wall St.
·
Jul 01

Dexcom Inc. Stock Underperforms Tuesday When Compared to Competitors

Dow Jones
·
Jul 01

20 Stocks in the S&P 500 That Plunged the Most in 2026's First Half

Dow Jones
·
Jun 30

Insulet Corp. Stock Outperforms Competitors on Strong Trading Day

Dow Jones
·
Jun 26

Insulet Names Ex-idexx CEO Jay Mazelsky to Board, Effective July 1, 2026

Reuters
·
Jun 25

Insulet Announces Appointment of Jonathan J. Mazelsky to Its Board of Directors

THOMSON REUTERS
·
Jun 25